NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 3 filers reported holding NOVOCURE LTD in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,672 | -66.4% | 475 | -13.6% | 0.01% | -66.7% |
| Q2 2023 | $22,825 | -31.0% | 550 | 0.0% | 0.02% | -34.8% |
| Q1 2023 | $33,077 | -18.0% | 550 | 0.0% | 0.02% | -20.7% |
| Q4 2022 | $40,342 | -3.9% | 550 | 0.0% | 0.03% | -14.7% |
| Q3 2022 | $42,000 | +10.5% | 550 | 0.0% | 0.03% | +21.4% |
| Q2 2022 | $38,000 | -17.4% | 550 | 0.0% | 0.03% | +3.7% |
| Q1 2022 | $46,000 | +12.2% | 550 | 0.0% | 0.03% | +28.6% |
| Q4 2021 | $41,000 | -35.9% | 550 | 0.0% | 0.02% | -43.2% |
| Q3 2021 | $64,000 | -47.5% | 550 | 0.0% | 0.04% | -46.4% |
| Q2 2021 | $122,000 | +67.1% | 550 | 0.0% | 0.07% | +46.8% |
| Q1 2021 | $73,000 | -23.2% | 550 | 0.0% | 0.05% | -31.9% |
| Q4 2020 | $95,000 | +55.7% | 550 | 0.0% | 0.07% | +23.2% |
| Q3 2020 | $61,000 | +84.8% | 550 | 0.0% | 0.06% | +55.6% |
| Q2 2020 | $33,000 | -10.8% | 550 | 0.0% | 0.04% | -23.4% |
| Q1 2020 | $37,000 | -5.1% | 550 | +19.6% | 0.05% | +46.9% |
| Q4 2019 | $39,000 | +14.7% | 460 | 0.0% | 0.03% | 0.0% |
| Q3 2019 | $34,000 | +750.0% | 460 | +666.7% | 0.03% | +700.0% |
| Q2 2019 | $4,000 | – | 60 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $39,681,000 | 20.12% |
| HARTLINE INVESTMENT CORP/ | 330,672 | $27,866,000 | 5.97% |
| MORGAN JESS S & CO INC | 52,889 | $4,457,000 | 4.37% |
| Darsana Capital Partners LP | 1,350,000 | $113,765,000 | 3.88% |
| Rhenman & Partners Asset Management AB | 350,000 | $29,495,000 | 3.23% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $843,000 | 2.55% |
| Taylor Frigon Capital Management LLC | 38,073 | $3,208,000 | 2.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,500 | $2,991,000 | 1.08% |
| Granite Investment Partners, LLC | 261,315 | $22,021,000 | 1.04% |
| Nicholas Investment Partners, LP | 85,835 | $7,233,000 | 0.74% |